Bayer's Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology | Business
WHIPPANY, N.J.--(BUSINESS WIRE)--Aug 31, 2023--
Stay updated with breaking news from Accessed May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WHIPPANY, N.J.--(BUSINESS WIRE)--Aug 31, 2023--
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.
This report describes age group-specific features of mpox among adults compared to features in adults over 50 years old by JYNNEOS vaccination status.
The approval of ELREXFIO is based on clinically meaningful response rates and duration of response from Phase 2 MagnetisMM-3 study ELREXFIO is the first off-the-shelf fixed-dose subcutaneous... -Today at 02:09 pm- MarketScreener
Psychiatry: a field of medicine that is constantly evolving.